Seattle Institute for Cardiac Research

Implanted defibrillator reduces heart failure deaths

Published in Cardiovascular Device Liability Week, April 4th, 2004

An implantable cardiac defibrillator (ICD) significantly reduces deaths in heart failure patients, according to a new study supported by the National Heart, Lung, and Blood Institute (NHLBI), one of the U.S. National Institutes of Health. The study also found that treatment with the antiarrhythmic drug amiodarone does not reduce deaths in these patients.

Preliminary results from the study - called "Sudden Cardiac Death in Heart Failure" (SCD-HeFT) - were presented at the American College of Cardiology Annual Scientific Session 2004 in New Orleans.

"These findings should have a big impact on the treatment of heart failure patients," said NHLBI Acting...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cardiovascular Device Liability Week

Source: Cardiovascular Device Liability Week (2004-04-04)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry